Lilly invests in epigenetic reprogramming biotech
NewLimit adds $45m in new funding at a $1.6bn valuation following preclinical progress that brings clinical trials closer…
A New Concept to Support Brain Recovery in
LONDON, Oct. 10, 2025 (GLOBE NEWSWIRE) — Concern over the long-term effects of head injuries in rugby and American…